These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 227475)

  • 1. The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis.
    Keppens S; de Wulf H
    Biochim Biophys Acta; 1979 Nov; 588(1):63-9. PubMed ID: 227475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of vasopressin-related peptides on glycogen metabolism in the perfused rat liver.
    Whitton PD; Hems DA
    Biochem Pharmacol; 1976 Feb; 25(4):405-7. PubMed ID: 181000
    [No Abstract]   [Full Text] [Related]  

  • 3. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
    Bankowski K; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
    Lempicka E; Slaninova J; Olma A; Lammek B
    J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions.
    Hems DA; Rodrigues LM; Whitton PD
    Biochem J; 1978 May; 172(2):311-7. PubMed ID: 666748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and oxytocin reduce plasma prolactin levels of conscious rats in basal and stress conditions. Study of the characteristics of the receptor involved.
    Mormede P; Vincent JD; Kerdelhue B
    Life Sci; 1986 Nov; 39(19):1737-43. PubMed ID: 3022094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
    Manning M; Lowbridge J; Stier CT; Haldar J; Sawyer WH
    J Med Chem; 1977 Sep; 20(9):1228-30. PubMed ID: 926126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between receptor binding capacity for norepinephrine, angiotensin II, and vasopressin and release of inositol trisphosphate, Ca2+ mobilization, and phosphorylase activation in rat liver.
    Lynch CJ; Blackmore PF; Charest R; Exton JH
    Mol Pharmacol; 1985 Aug; 28(2):93-9. PubMed ID: 2991741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats.
    Chen DL; Chan WY; Manning M
    J Reprod Fertil; 1994 Nov; 102(2):337-43. PubMed ID: 7861386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist.
    Burnard DM; Veale WL; Pittman QJ
    Brain Res; 1986 Jan; 362(1):40-6. PubMed ID: 2867814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vasopressin receptors of rat urinary bladder and spleen.
    Thibonnier M; Snajdar RM; Rapp JP
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H115-20. PubMed ID: 3014903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hormonal activation of hepatic phosphorylase by chlorpropamide: evidence for an intracellular site of drug action.
    Blumenthal SA; Moses AM
    Endocrinology; 1985 Feb; 116(2):660-4. PubMed ID: 3967624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (3H)-vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and relation to glycogen phosphorylase activation.
    Cantau B; Keppens S; De Wulf H; Jard S
    J Recept Res; 1980; 1(2):137-68. PubMed ID: 6271952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II.
    Hems DA; Rodrigues LM; Whitton PD
    Biochem J; 1976 Nov; 160(2):367-74. PubMed ID: 827289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of vasopressin and oxytocin on the spontaneous activity of dorsal horn cells of the isolated spinal cord of the rat pup].
    Tamarova ZA
    Neirofiziologiia; 1985; 17(3):314-20. PubMed ID: 4022179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of V1 vasopressin receptors in rabbit hepatocytes.
    Vandekerckhove A; Miot F; Keppens S; De Wulf H
    Biochem J; 1989 Apr; 259(2):609-11. PubMed ID: 2524192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of glycogen synthase and phosphorylase in hepatocytes from diabetic rats. Effects of glucagon, vasopressin, and vanadate.
    Rodríguez-Gil JE; Gómez-Foix AM; Ariño J; Guinovart JJ; Bosch F
    Diabetes; 1989 Jun; 38(6):793-8. PubMed ID: 2498142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohypophysial peptides and the hippocampus. II. Excitation of rat hippocampal neurones by oxytocin and vasopressin applied in vitro.
    Tiberiis BE; McLennan H; Wilson N
    Neuropeptides; 1983 Dec; 4(1):73-86. PubMed ID: 6669225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.